Wells Fargo Downgrades Health Catalyst to Equal-Weight, Lowers Price Target to $1

Benzinga Newsdesk www.benzinga.com Negative 68.6%

Neg 68.6% Neu 0% Pos 0%

Wells Fargo analyst Stan Berenshteyn downgrades Health Catalyst (NASDAQ:HCAT) from Overweight to Equal-Weight and lowers the price target from $5 to $1.